Acadian Asset Management’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Buy |
45,806
+24,665
| +117% | +$165K | ﹤0.01% | 1230 |
|
|
2025
Q1 | $190K | Sell |
21,141
-30,350
| -59% | -$273K | ﹤0.01% | 1266 |
|
|
2024
Q4 | $890K | Sell |
51,491
-14,032
| -21% | -$243K | ﹤0.01% | 947 |
|
|
2024
Q3 | $1.04M | Buy |
65,523
+52,156
| +390% | +$829K | ﹤0.01% | 902 |
|
|
2024
Q2 | $190K | Buy |
13,367
+7,682
| +135% | +$109K | ﹤0.01% | 1434 |
|
|
2024
Q1 | $79K | Buy |
+5,685
| New | +$79K | ﹤0.01% | 1321 |
|